Tuvonralimab

Tax included
Tuvonralimab (PSB-205; QL1706) is a dual immune checkpoint blockade containing a mixture of anti-PD-1 IgG4 and anti-CTLA-4 IgG1 antibodies, Iparomlimab and Tuvonralimab.
MedChemExpress 
HY-P99540

Data sheet

Size
Multiple sizes
Reactivity
PD-1/PD-L1; CTLA-4
CAS
2417649-44-4